These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8120895)

  • 21. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
    Mylvaganam SE; Paterson Y; Getzoff ED
    J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.
    Schulze-Gahmen U; Rini JM; Wilson IA
    J Mol Biol; 1993 Dec; 234(4):1098-118. PubMed ID: 8263915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex.
    Liu H; Smith TJ; Lee WM; Mosser AG; Rueckert RR; Olson NH; Cheng RH; Baker TS
    J Mol Biol; 1994 Jul; 240(2):127-37. PubMed ID: 8027997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of the respective loops at complementarity determining region on the antigen-antibody recognition.
    Osajima T; Hoshino T
    Comput Biol Chem; 2016 Oct; 64():368-383. PubMed ID: 27591792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of Fab198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodies.
    Poulas K; Eliopoulos E; Vatzaki E; Navaza J; Kontou M; Oikonomakos N; Acharya KR; Tzartos SJ
    Eur J Biochem; 2001 Jul; 268(13):3685-93. PubMed ID: 11432734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations.
    Král V; Mader P; Collard R; Fábry M; Horejsí M; Rezácová P; Kozísek M; Závada J; Sedlácek J; Rulísek L; Brynda J
    Proteins; 2008 May; 71(3):1275-87. PubMed ID: 18041760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
    Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
    J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the three-dimensional structure of two human rhinoviruses (HRV2 and HRV14).
    Blaas D; Kuechler E; Vriend G; Arnold E; Luo M; Rossmann MG
    Proteins; 1987; 2(4):263-72. PubMed ID: 2834716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of antibody hypervariable loops reproduced by a conformational search algorithm.
    Bruccoleri RE; Haber E; Novotný J
    Nature; 1988 Oct; 335(6190):564-8. PubMed ID: 3419534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
    Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
    J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of a Human Astrovirus Capsid-Antibody Complex and Mechanistic Insights into Virus Neutralization.
    Bogdanoff WA; Campos J; Perez EI; Yin L; Alexander DL; DuBois RM
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
    Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
    Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralizing epitopes on the extracellular interferon gamma receptor (IFNgammaR) alpha-chain characterized by homolog scanning mutagenesis and X-ray crystal structure of the A6 fab-IFNgammaR1-108 complex.
    Sogabe S; Stuart F; Henke C; Bridges A; Williams G; Birch A; Winkler FK; Robinson JA
    J Mol Biol; 1997 Nov; 273(4):882-97. PubMed ID: 9367779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling the binding sites of anti-hen egg white lysozyme antibodies HyHEL-8 and HyHEL-26: an insight into the molecular basis of antibody cross-reactivity and specificity.
    Mohan S; Sinha N; Smith-Gill SJ
    Biophys J; 2003 Nov; 85(5):3221-36. PubMed ID: 14581222
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Holland CJ; MacLachlan BJ; Bianchi V; Hesketh SJ; Morgan R; Vickery O; Bulek AM; Fuller A; Godkin A; Sewell AK; Rizkallah PJ; Wells S; Cole DK
    Front Immunol; 2018; 9():674. PubMed ID: 29696015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding.
    Pantazes RJ; Maranas CD
    Protein Eng Des Sel; 2010 Nov; 23(11):849-58. PubMed ID: 20847101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2.
    Hastings GZ; Speller SA; Francis MJ
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():3055-9. PubMed ID: 1703215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.